Skip to main content

Conclusions- Ehealth Practice and Application




Well, offlate I received a Huge amount of Inputs from the readers on my blog, Thanks to Didar, Ajay, Pankaj, David, Nitin and all of you. I am hereby drawing certain conclusions out of those Case studies which I received and studied.



Steps required for Such Conclusions:



(1) Create a framework for country studies.


(2) Identify focal points – regional and national (WHO and Member State).


(3) Set up an interdisciplinary and interministry expert group.


(4) Select/appoint a national consultant.


(5) Carry out research on the basis of the framework.


(6) Monitor, review and finalize the study.


(7) Identify gaps.


(8) Build capacity.


(9) Devise strategies.


(10) Establish task group to carry forward initiative.



High-quality infrastructure is one of the most important prerequisites for fostering the growth of the e-health industry. (The main determinants of the e-business environment for health are technology, connectivity, bandwidth availability, telephone charges, power supply and real estate.)



India is aware of the crucial role of infrastructure and is opening up to private sector partnerships on a large scale in order to strengthen it. The infrastructure needs to be developed further. There is also a need for quality incubators (initiators) to promote entrepreneurship, and more biotechnological facilities such as the Indian Institute of Science, Bangalore. Technological barriers hinder the progress of cross-border trade. There is a need for sufficient internet bandwidth. The cost of internet access has to be brought down, outdated applications must be eliminated, and interoperability across different platforms needs to be promoted.



As legal support plays a major role in creating an environment conducive to compliance, the legal framework needs to be user-friendly and easy to implement at all levels. However, currently, no effective legal framework exists in India for cross-border trade. There is lack of clear definition with regard to the legal requirements and implications of getting into businesses such as contract research, medical transcription, medical coding and billing, all of which deal with confidential health information. In 2001, India promulgated the Information Technology Act for the purpose of facilitating e-governance and ecommerce in the country. The Act also seeks to curb cyber crime and regulate the online environment.



This poses a serious threat to health-care companies outsourcing work to India.

Also a very low level of awareness of country-specific healthcare regulations, such as the Health Insurance Portability and Accountability Act of 1996 (HIPAA) is a turn-off.



As far as Manpower is concerned , the workforce was found lacking in domain knowledge of health-care administration and financing, despite the considerable amount of BPO work being done in this area. The supply of health-care professionals does not meet the demand. Also all of us know about limited acceptance of Indian health-care qualifications in developed countries.



Why our E-health models don’t scale and lag?



The promotion of remote diagnosis for US-based patients by Indian doctors in India would require the doctors to hold United States Medical Licensing Examination (USMLE) certificates. This makes the BPO model in this area of health care restrictive. If Indian health-care professionals want to demand high-end work and higher prices, they will need to be certified by US industry associations, such as the American Health Information Management Association (AHIMA) and American Academy of Professional Coders (AAPC) for medical coders. A good understanding of health informatics could revolutionize the way health information is captured, stored, analyzed, applied and shared.



All said, There is still plenty of room for Indian e-health service companies to enter areas such as telemedicine, clinical trials, disease management, and management of health-care knowledge, as well as that of electronic medical records.



Keep on rolling Guys.


Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki